PTGX
Protagonist Therapeutics Inc
$45.53
Earnings Summary
Revenue | $4.68Mn |
Net Profits | $-33.21Mn |
Net Profit Margins | -710.37% |
Highlights
Protagonist Therapeutics Inc’s revenue jumped +Inf% since last year same period to $4.68Mn in the Q3 2024. On a quarterly growth basis, Protagonist Therapeutics Inc has generated 12.19% jump in its revenue since last 3-months.
Protagonist Therapeutics Inc’s net profit jumped 2.62% since last year same period to $-33.21Mn in the Q3 2024. On a quarterly growth basis, Protagonist Therapeutics Inc has generated -8.47% fall in its net profits since last 3-months.
Protagonist Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -710.37% in the Q3 2024. On a quarterly growth basis, Protagonist Therapeutics Inc has generated 3.31% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Protagonist Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.6 |
EPS Estimate Current Year | -0.6 |
Highlights
Protagonist Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.6 - a 0% jump from last quarter’s estimates.
Protagonist Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.6.
Key Ratios
Key ratios of the Protagonist Therapeutics Inc post its Q3 2024 earnings
Earning Per Share (EPS) | -0.54 |
Highlights
Protagonist Therapeutics Inc’s earning per share (EPS) jumped 6.9% since last year same period to -0.54 in the Q3 2024. This indicates that the Protagonist Therapeutics Inc has generated 6.9% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-07 | -0.6 | -0.54 | 10% |
2024-05-07 | 1.19 | 3.26 | 173.95% |
2024-08-06 | -0.6 | -0.5 | 16.67% |
₹0 US Stocks a/c Opening Fee